. Author manuscript; available in PMC: 2015 Jan 1.

Published in final edited form as: Am J Cardiol. 2013 Oct 4;113(1):10.1016/j.amjcard.2013.09.028. doi: 10.1016/j.amjcard.2013.09.028

Table 4.

Multivariable analyses relating left ventricular hypertrophy patterns to incident heart failure.

Adjusted Hazards Ratio^* for HF (95% CI)
Normal LV	Concentric Remodeling	Concentric Hypertrophy	Eccentric Hypertrophy	p-value^†
A. All participants (n = 4768)
Referent	1.09 (0.85-1.40)	1.40 (1.04-1.87)	1.89 (1.41-2.54)	0.0002
B. Participants with normal FS (FS >0.29; n = 4700)
Referent	1.21 (0.94-1.57)	1.52 (1.13-2.05)	1.78 (1.31-2.41)	0.0009
C. Participants without clinical valve disease (n = 4678)
Referent	1.16 (0.90-1.50)	1.38 (1.02-1.87)	1.70 (1.25-2.32)	0.005

Hazard ratios indicate HF risk associated with individual hypertrophy patterns compared to the group with normal LV (referent), and adjusted for the following covariates: age, sex, body mass index, systolic blood pressure, valve disease, hypertension treatment, diabetes, total cholesterol/high density lipoprotein cholesterol ratio, smoking status, fractional shortening and interim MI.

^†

P-value indicates statistical significance (p<0.05) for the global test for differences among the 4 LV patterns with respect to HF risk.